The healthcare system in the United States is changing, particularly in oncology. As outpatient clinics and hospitals move towards value-based care (VBC) models, artificial intelligence (AI) is becoming important for improving patient outcomes, simplifying operations, and cutting costs. The use of AI in value-based oncology practices may redefine care models and assist medical practice administrators, owners, and IT managers in managing this changing landscape.
Value-based care models focus on patient outcomes rather than the quantity of services delivered. The aim is to enhance the quality of care while reducing unnecessary costs. According to the Centers for Medicare & Medicaid Services (CMS), about 60% of healthcare payments in the U.S. are already tied to these value-based models. The goal is to enroll all Medicare beneficiaries and most Medicaid beneficiaries in value-based programs by 2030. Key models include:
The Oncology Care Model (OCM) from CMS encourages practices to improve care management. Under this model, practices receive reimbursement based on the quality of care provided rather than the number of services rendered.
AI applications are increasingly used to analyze large amounts of data for better patient management in oncology. A review of different studies has found eight key areas where AI proves effective in oncology:
AI can process and analyze complex data, helping oncologists make better treatment decisions. For example, a study at the Center for Cancer and Blood Disorders used AI from Jvion to analyze over 4,000 variables per patient. This helps understand the specific needs and risks of each patient, leading to improved treatment outcomes.
Dr. Ray Page from the Center for Cancer and Blood Disorders noted that traditional clinic visits often lack time to consider non-clinical factors impacting patient outcomes, such as financial stability and access to transportation. AI can identify these factors during patient interactions.
Understanding Social Determinants of Health (SDOH) is crucial for effective value-based care in oncology. Research shows that factors like financial stability, transportation access, and food availability have a significant impact on cancer patient outcomes. Nearly 90% of oncologists see SDOH as an important factor in treatment success.
AI tools help practices assess these determinants effectively. In California, using AI in a community oncology setting led to over $3.1 million in savings in Medicare payments over six months due to fewer emergency room visits and hospitalizations. Practices that adopted AI technologies saw a 225% increase in hospice referrals and a 35% increase in palliative care appointments.
This demonstrates how AI can help oncologists focus on patient care, particularly for vulnerable populations facing multiple SDOH-related challenges.
With a focus on improving patient outcomes, healthcare practices are facing more administrative tasks. However, AI can help manage some of this workload through automation. By automating routine tasks, healthcare professionals can spend more time on patient care.
For example, the Geisinger Intelligent Automation Hub implemented 85 bots by 2022, saving nearly 897,000 “digital hours” and approximately $40.5 million in labor costs. Practices that used automation for patient outreach and communications saw significant improvements in engagement rates.
AI allows clinicians to send personalized messages to patients without requiring too much manual effort. This helps maintain patient relationships while reducing the administrative burden on healthcare workers. Such improvements can boost job satisfaction and enhance the quality of care provided.
Another aspect of AI-driven automation involves using real-time health data to guide clinical decisions. Access to actionable data at the point of care helps healthcare administrators and IT managers coordinate resources and prioritize interventions better.
Systems like Vantage Health’s SocialHealth360 enable practices to use real-time data to meet complex patient needs. Armed with detailed insights, care teams can effectively address health equity issues and develop more tailored care plans. This supports the shift toward value-based oncology aimed at delivering the right care for each patient in a timely manner.
In value-based care models, patient-centered approaches are key to achieving favorable health outcomes. AI tools help improve communication between patients and healthcare teams, leading to more engaged patients.
Practices can use AI for personalized patient engagement to communicate more effectively. This includes sending reminders for screenings and follow-ups, informing patients about clinical trials, and gathering feedback on their care experiences.
Dr. Brett Oliver, a figure in value-based care, emphasized the importance of involving patients in care decisions. AI tools can improve the quality of these interactions, allowing providers to customize their approach based on patient preferences while offering valuable insights to the healthcare team.
While AI offers clear benefits in oncology, there are also challenges to address. Gaining acceptance from physicians remains a challenge, especially concerning fears of job displacement and liability issues. Additionally, integrating AI into existing clinical workflows can disrupt established practices if not handled properly.
The American Medical Association (AMA) emphasizes the need for transparent AI management to alleviate these concerns. Practitioners must feel assured that AI enhances their care methods rather than complicating them. Organizations also need to consider the costs associated with implementing AI systems, addressing financial discussions early in the process.
As technology continues to influence healthcare, the future of value-based oncology practices will likely be shaped by AI and data analytics. The ongoing integration of these tools will enable better communication, improved patient management, and enhanced treatment outcomes.
Future healthcare models may focus more on personalized medicine, as oncology practices increasingly adopt AI-driven predictive analytics. This may lead to greater access to clinical trials, fairer resource distribution, and comprehensive strategies targeting high-risk patients.
AI has become an important resource in advancing value-based care models within oncology. The benefits it brings contribute to better patient outcomes and assist healthcare providers in cutting costs and managing administrative demands. The continued development of AI will influence workflows, patient engagement, and the understanding of Social Determinants of Health, further embedding value-based practices in oncology throughout the U.S. As more practices implement these solutions, collaboration across departments will be essential for achieving value-based care goals.
By adopting AI technologies, medical practice administrators, owners, and IT managers can better align their operations with the future direction of healthcare delivery, thus improving care models in meaningful ways.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
